Ionizable Lipid Composition for High mRNA Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for delivering nucleic acids, particularly mRNA, face challenges in achieving high encapsulation rates and dose-dependent protein expression, with limitations in gene size and safety concerns associated with viral vectors.
Innovation Solution
A lipid composition comprising specific compounds represented by Formula (1) or their salts, which include hydrocarbon groups and functional substituents, is used to enhance nucleic acid encapsulation and delivery, achieving high encapsulation rates and dose-dependent protein production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral vectors are used for gene delivery, then gene introduction efficiency is improved, but gene size is limited and immunogenicity and safety concerns arise
Solution Approach 1:
The patent modifies the chemical structure of lipid components in the delivery system by adjusting hydrocarbon chain lengths (R1: 1-24 carbons, R3: 6-24 carbons with branched chain), substituent positions, and molecular weight parameters to optimize nucleic acid encapsulation and delivery efficiency without the size constraints of viral vectors
Solution Approach 2:
The invention uses composite lipid compositions comprising multiple lipid types (ionizable lipids, helper lipids, cholesterol, PEG-lipids) in specific ratios to create a synergistic delivery system that achieves high transfection efficiency while accommodating various nucleic acid sizes and reducing immunogenicity
2Adaptability or versatility
If conventional lipid compositions are used for nucleic acid delivery, then any gene can be introduced without size limitation, but nucleic acid encapsulation rate and delivery efficiency are insufficient
Solution Approach 1:
The patent optimizes specific parameters of the ionizable lipid structure including hydrocarbon chain length (R1, R3), substituent groups (R4, R5), and molecular weight to enhance nucleic acid binding affinity and encapsulation efficiency while maintaining size flexibility for different gene payloads
Solution Approach 2:
The invention introduces specific functional groups at defined positions on the lipid molecule (R4 and R5 substituents at positions 2 and 3 of the nitrogen-containing six-membered ring) to create localized interactions that improve nucleic acid complexation and cellular uptake efficiency
3Adaptability or versatility
If mRNA is used for protein expression, then protein production is possible, but high encapsulation rate and dose-dependent expression are difficult to achieve
Solution Approach 1:
The patent adjusts the pKa and hydrophobicity parameters of the ionizable lipid through structural modifications (hydrocarbon groups R1, R3 with specific carbon numbers, substituent R4, R5) to optimize mRNA encapsulation stability and enable dose-dependent protein expression in a controlled manner
Solution Approach 2:
The lipid composition is designed to dynamically respond to cellular environment changes (pH gradients from endosome to cytoplasm) through protonation/deprotonation of the ionizable nitrogen, enabling efficient mRNA release and dose-dependent protein expression while maintaining encapsulation stability during circulation
Data Source
AI summary
A compound or a salt thereof which facilitates the introduction of a nucleic acid into a cell or the like is provided. Also provided are a lipid composition, a pharmaceutical composition, and a delivery carrier which employ the compound or a salt thereof, and which are capable of realizing a high nucleic acid encapsulation rate and excellent nucleic acid delivery in a case where mRNA is used. Thus, a compound represented by Formula (1) or a salt thereof is provided,wherein R1 represents a hydrocarbon group having 1 to 24 carbon atoms, R2 represents a hydrocarbon group having 1 to 6 carbon atoms, R3 represents a hydrocarbon group having 6 to 24 carbon atoms and having a branched chain, R4 and RS represent a hydrocarbon group having 1 to 6 carbon atoms, which may be substituted, R6 represents a hydrogen atom or a hydrocarbon group having 1 to 18 carbon atoms, L represents *—O—C(O)— or *—C(O)O—, a represents an integer of 1 to 12, and b, c, and d represent an integer of 1 to 4.